You just read:

Braeburn Announces FDA Advisory Committee Recommends Approval of CAM2038 Buprenorphine Depot for the Treatment of Opioid Use Disorder

News provided by

Braeburn Pharmaceuticals, Inc.

Nov 01, 2017, 15:32 ET